- Table of Contents
Unlock in-depth insights with Boster’s Multiplex IHC Service
Investigate disease mechanisms, diagnostics and personalized medicine with Multiplex IHC
Boster has been manufacturing antibodies and reagents for pathology/IHC
since 1993. Our founder came from a medical histology background and IHC
has been in the company's DNA from day 1. With hundreds of IHC experiments
performed each week and after 3 decades of continuous improvement, Boster's
technical team has mastered the art of IHC. Till end of 2022, there were
more than 5,000 articles published using IHC results obtained from Boster
antibodies (source: Google Scholar, Bioz and CiteAb). With our history and
size, Boster is expanding our IHC service to include multiplex IHC.
More details on Boster's IHC service can be found here
Multiplex Immunochemistry or IHC allows for the quantification of multiple markers in a single sample, giving a comprehensive view of cellular or tissue composition. Multiplex IHC can show spatial data for one protein relative to another, tissue architecture and organelle structure, leading to improved insights in disease mechanisms, diagnostics, and the effects of personalized medicine. It has become an invaluable tool in determining the subsets of immune-oncology markers within the tumor microenvironment and the relativity of co-expressing markers in cells.
It is our project concierges' mission to make your project experience as smooth and memorable as possible. They are subject matter experts who are easily accessible around the clock, always happy to help you solve problems, make recommendations and sort through options.
We offer a list of pre-validated IHC antibodies available for this service. If you prefer to use your own antibodies this is possible so long as they has been validated to work in IHC. Boster also offers an antibody IHC validation and optimization service which can be found using the link below.IHC Validation and Optimization Service
concierge like service
ELISA kits developed